TMDX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Core Viewpoint - A class action lawsuit has been filed against TransMedics Group, Inc. for alleged violations of federal securities laws, with claims of misleading statements and unsafe practices [1][2][3]. Group 1: Lawsuit Details - The lawsuit seeks to recover damages for all individuals and entities that purchased TransMedics securities between February 3, 2022, and February 3, 2025 [2]. - Allegations include the use of kickbacks, fraudulent overbilling, and coercive tactics to generate revenue, as well as a lack of safety oversight [3]. Group 2: Next Steps for Investors - Investors who suffered losses in TransMedics have until April 15, 2025, to request appointment as lead plaintiff in the case [4]. - A copy of the Complaint can be reviewed on the law firm's website [4]. Group 3: Legal Representation - The law firm operates on a contingency fee basis, meaning they will only seek reimbursement for expenses and fees if successful [5]. - Bronstein, Gewirtz & Grossman, LLC has a history of recovering hundreds of millions of dollars for investors in securities fraud cases [6].